This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Danaher's bid to acquire medical technology company Masimo reviewed in Australia

( April 2, 2026, 12:20 GMT | Official Statement) -- MLex Summary: Global science and technology company Danaher Corporation’s proposal to acquire 100 percent of the outstanding share capital of Masimo Corporation will face review by Australia’s antitrust watchdog. In a statement issued Thursday, the Australian Competition & Consumer Commission said Danaher designs, manufactures and markets medical, industrial and commercial products and services across biotechnology, life sciences and diagnostics. Masimo, a global medical technology company, provides pulse oximetry and other patient sensors and monitoring solutions. The watchdog is seeking feedback on the deal through April 13 via a questionnaire.Statement follows. Questionnaire is attached.Danaher Corporation / Masimo Corporation...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections